Bill Snyder

March 14, 2013

New center to focus on treating, preventing TB

Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world.

By Bill Snyder
March 7, 2013

Harvard’s Seidman to speak at VU

Jonathan Seidman, Ph.D., who has made pivotal contributions to understanding the genetic basis of cardiomyopathy and other heart diseases, will deliver the next Flexner Discovery Lecture on Thursday, March 14.

By Bill Snyder
March 4, 2013

Gene ‘dose’ may be key to autism

Individuals with overexpression of the gene MECP2 have core features of autism spectrum disorder.

By Bill Snyder
February 28, 2013

Potent genetic risk factor for breast cancer identified

Researchers at Vanderbilt University have found a powerful new genetic risk factor for breast cancer.

By Bill Snyder
February 28, 2013

Institute of Chemical Biology to celebrate 10th anniversary

Top chemists from around the country will be on hand March 12 to celebrate the 10th anniversary of the Vanderbilt Institute of Chemical Biology (VICB), a brave experiment that helped jumpstart the University’s robust drug discovery initiative.

By Bill Snyder
February 28, 2013

Discovery Lecture explores brain’s sensitivity to insulin

Diabetes has a big impact on the brain.

By Bill Snyder
February 21, 2013

Series of events explore brain disorders, neuroscience research

“Brain Blast,” a half-day of free, hands-on activities for children and adults will be held from 9 a.m. to 1 p.m., Saturday, March 2, at Vanderbilt Health One Hundred Oaks.
By Bill Snyder
February 15, 2013

Cure in sight for kissing bug’s bite

It’s possible to cure Chagas disease – a deadly tropical infection transmitted by “kissing bugs” – in a mouse model.
By Bill Snyder
February 14, 2013

Vaccination still key defense as flu season continues

As is the case throughout the country, this year’s flu season in Middle Tennessee is hitting elderly people particularly hard.
By Bill Snyder
February 14, 2013

Harvard’s Kahn set for Discovery Lecture

C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21.
By Bill Snyder
February 11, 2013

VU, GlaxoSmithKline team to develop novel treatments for severe obesity

Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.
By Bill Snyder
February 7, 2013

Humble yeast helps predict how genes are regulated

Budding yeast occupies a place of honor in the pantheon of human history. Saccharomyces cerevisiae has been used for baking and alcoholic fermentation for thousands of years.
By Bill Snyder